| Long non-coding RNA NEAT1 promotes bone metastasis of prostate cancer through N6-methyladenosine S Wen, Y Wei, C Zen, W Xiong, Y Niu, Y Zhao Molecular cancer 19, 1-18, 2020 | 205 | 2020 |
| Androgen receptor (AR) positive vs negative roles in prostate cancer cell deaths including apoptosis, anoikis, entosis, necrosis and autophagic cell death S Wen, Y Niu, SO Lee, C Chang Cancer treatment reviews 40 (1), 31-40, 2014 | 127 | 2014 |
| Stromal androgen receptor roles in the development of normal prostate, benign prostate hyperplasia, and prostate cancer S Wen, HC Chang, J Tian, Z Shang, Y Niu, C Chang The American journal of pathology 185 (2), 293-301, 2015 | 105 | 2015 |
| BM-MSCs promote prostate cancer progression via the conversion of normal fibroblasts to cancer-associated fibroblasts S Wen, Y Niu, S Yeh, C Chang International journal of oncology 47 (2), 719-727, 2015 | 66 | 2015 |
| FOXA1 overexpression suppresses interferon signaling and immune response in cancer Y He, L Wang, T Wei, YT Xiao, H Sheng, H Su, DP Hollern, X Zhang, J Ma, ... The Journal of clinical investigation 131 (14), 2021 | 59 | 2021 |
| Posttranslational regulation of androgen dependent and independent androgen receptor activities in prostate cancer S Wen, Y Niu, H Huang Asian journal of urology 7 (3), 203-218, 2020 | 53 | 2020 |
| ADT with antiandrogens in prostate cancer induces adverse effect of increasing resistance, neuroendocrine differentiation and tumor metastasis Y Niu, C Guo, S Wen, J Tian, J Luo, K Wang, H Tian, S Yeh, C Chang Cancer letters 439, 47-55, 2018 | 51 | 2018 |
| Targeting fatty acid synthase with ASC‐J9 suppresses proliferation and invasion of prostate cancer cells S Wen, Y Niu, SO Lee, S Yeh, Z Shang, H Gao, Y Li, F Chou, C Chang Molecular carcinogenesis 55 (12), 2278-2290, 2016 | 50 | 2016 |
| Aberrant activation of super enhancer and choline metabolism drive antiandrogen therapy resistance in prostate cancer S Wen, Y He, L Wang, J Zhang, C Quan, Y Niu, H Huang Oncogene 39 (42), 6556-6571, 2020 | 37 | 2020 |
| Androgen receptor enhances entosis, a non‐apoptotic cell death, through modulation of Rho/ROCK pathway in prostate cancer cells S Wen, Z Shang, S Zhu, C Chang, Y Niu The Prostate 73 (12), 1306-1315, 2013 | 37 | 2013 |
| Neurotensin and its receptors mediate neuroendocrine transdifferentiation in prostate cancer S Zhu, H Tian, X Niu, J Wang, X Li, N Jiang, S Wen, X Chen, S Ren, C Xu, ... Oncogene 38 (24), 4875-4884, 2019 | 34 | 2019 |
| Functional roles of antisense enhancer RNA for promoting prostate cancer progression CW Pan, S Wen, L Chen, Y Wei, Y Niu, Y Zhao Theranostics 11 (4), 1780, 2021 | 28 | 2021 |
| ASC-J9®, and not Casodex or Enzalutamide, suppresses prostate cancer stem/progenitor cell invasion via altering the EZH2-STAT3 signals S Wen, J Tian, Y Niu, L Li, S Yeh, C Chang Cancer letters 376 (2), 377-386, 2016 | 27 | 2016 |
| Targeting estrogen/estrogen receptor alpha enhances Bacillus Calmette-Guérin efficacy in bladder cancer Z Shang, Y Li, I Hsu, M Zhang, J Tian, S Wen, R Han, EM Messing, ... Oncotarget 7 (19), 27325, 2016 | 16 | 2016 |
| Enhancer RNA promotes resistance to radiotherapy in bone-metastatic prostate cancer by m6A modification Y Zhao, S Wen, H Li, CW Pan, Y Wei, T Huang, Z Li, Y Yang, S Fan, ... Theranostics 13 (2), 596, 2023 | 13 | 2023 |
| Impact of long non-coding RNAs associated with microenvironment on survival for bladder cancer patients G Lin, B Guo, Y Wei, T Lan, S Wen, G Li Frontiers in Genetics 11, 567200, 2020 | 7 | 2020 |
| What is the next generation therapeutic strategy for castration-resistant prostate cancer SM Wen, CY Quan, N Jiang, ZQ Shang, YJ Niu Asian Journal of Andrology 17 (2), 223-224, 2015 | 6 | 2015 |
| P300/SP1 complex mediating elevated METTL1 regulates CDK14 mRNA stability via internal m7G modification in CRPC M Zhang, D Kan, B Zhang, X Chen, C Wang, S Chen, W Gao, Z Yang, Y Li, ... Journal of Experimental & Clinical Cancer Research 42 (1), 215, 2023 | 5 | 2023 |
| Six‐transmembrane epithelial antigen of prostate 3 (STEAP3) is a potential prognostic biomarker in clear cell renal cell carcinoma that correlates with M2 macrophage … H Wei, Z Li, Y Zhao, S Zhu, S Wen, C Quan Cancer Reports 6 (8), e1824, 2023 | 1 | 2023 |
| Identification of LAT/ZAP70 characterized immune subtypes of prostate cancer J Yu, W Gao, S Gao, S Wen, Y Zhao, Z Shang, Y Wang, Y Niu World Journal of Urology 40 (11), 2817-2824, 2022 | 1 | 2022 |
